4-Ethylbenzenesulfonamide
CAS: 138-38-5
Rif. 3D-FE145731
| 10g | Fuori produzione | ||
| 25g | Fuori produzione | ||
| 50g | Fuori produzione | ||
| 100g | Fuori produzione | ||
| 250g | Fuori produzione |
Informazioni sul prodotto
- Benzenesulfonamide, 4-ethyl-
- Benzenesulfonamide, p-ethyl-
- NSC 9909
- P-Ethylbenzenesulfonamide
4-Ethylbenzenesulfonamide is a compound that belongs to the class of blockers. It is used in the treatment of diabetes. The 4-ethylbenzenesulfonamide analog prevents the synthesis of acetyl coenzyme A, which is important for glucose production. This drug inhibits the activity of acetyl coenzyme A acylase, an enzyme involved in fatty acid metabolism. The 4-ethylbenzenesulfonamide analog has also been shown to inhibit viral polymerase and viral DNA synthesis by binding to subunits of these enzymes.
4-Ethylbenzenesulfonamide has been shown to be effective against hepatitis B virus (HBV) and hepatitis C virus (HCV). However, it does not inhibit human cytosolic or nuclear polymerases or other non-structural proteins such as those found in adenovirus, herpes simplex virus, influenza virus, and vaccinia virus.
